Aug. 28, 2014 | Press Release
Research and development, by definition, comes along with extraordinary risk. Entire industries and investment portfolios are colored by the simple fact that scientific and medical research takes huge upfront spending, patience, a high tolerance for losses.
What if all that changed thanks to big data analytics? Much of the estimated $600 billion spent by the world's top 1,000 research companies last year -- not to mention the time of their researchers -- would be up for reallocation. ...Link